Global Single Cell Multi-Omics Market Size, Status and Forecast 2020-2026
SKU ID :QYR-14378182 | Published Date: 29-Jan-2020 | No. of pages: 92Description
Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
Market Analysis and Insights: Global Single Cell Multi-Omics Market
In 2019, the global Single Cell Multi-Omics market size was US$ 1695.4 million and it is expected to reach US$ 3189.2 million by the end of 2026, with a CAGR of 9.3% during 2021-2026.
Global Single Cell Multi-Omics Scope and Market Size
Single Cell Multi-Omics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Single Cell Multi-Omics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Single Cell Multi-Omics market is segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics, etc.
Segment by Application, the Single Cell Multi-Omics market is segmented into Oncology, Cell Biology, Neurology, Immunology, Others, etc.
Regional and Country-level Analysis
The Single Cell Multi-Omics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Single Cell Multi-Omics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Single Cell Multi-Omics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Single Cell Multi-Omics business, the date to enter into the Single Cell Multi-Omics market, Single Cell Multi-Omics product introduction, recent developments, etc.
The major vendors include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee, BGI Genomics, GE LifeSciences, Illumina, Takara Bio, QIAGEN N.V., etc.
This report focuses on the global Single Cell Multi-Omics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Single Cell Multi-Omics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Oncology
Cell Biology
Neurology
Immunology
Others
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Single Cell Multi-Omics status, future forecast, growth opportunity, key market and key players.
To present the Single Cell Multi-Omics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Single Cell Multi-Omics are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Market Analysis and Insights: Global Single Cell Multi-Omics Market
In 2019, the global Single Cell Multi-Omics market size was US$ 1695.4 million and it is expected to reach US$ 3189.2 million by the end of 2026, with a CAGR of 9.3% during 2021-2026.
Global Single Cell Multi-Omics Scope and Market Size
Single Cell Multi-Omics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Single Cell Multi-Omics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Single Cell Multi-Omics market is segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics, etc.
Segment by Application, the Single Cell Multi-Omics market is segmented into Oncology, Cell Biology, Neurology, Immunology, Others, etc.
Regional and Country-level Analysis
The Single Cell Multi-Omics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Single Cell Multi-Omics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Single Cell Multi-Omics Market Share AnalysisSingle Cell Multi-Omics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Single Cell Multi-Omics business, the date to enter into the Single Cell Multi-Omics market, Single Cell Multi-Omics product introduction, recent developments, etc.
The major vendors include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee, BGI Genomics, GE LifeSciences, Illumina, Takara Bio, QIAGEN N.V., etc.
This report focuses on the global Single Cell Multi-Omics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Single Cell Multi-Omics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Market segment by Type, the product can be split into
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Market segment by Application, split into
Oncology
Cell Biology
Neurology
Immunology
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Single Cell Multi-Omics status, future forecast, growth opportunity, key market and key players.
To present the Single Cell Multi-Omics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Single Cell Multi-Omics are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
TOC
Tables & Figures
Companies
- PRICE
-
$3900$7800Buy Now